Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,273,778 | +776.3% | 417,207 | +991.8% | 0.00% | – |
| Q2 2023 | $259,467 | -83.5% | 38,213 | -87.9% | 0.00% | – |
| Q1 2023 | $1,577,198 | -66.5% | 314,810 | -67.4% | 0.00% | -100.0% |
| Q4 2022 | $4,708,326 | +128.0% | 964,821 | +573.5% | 0.00% | – |
| Q3 2022 | $2,065,000 | +51.2% | 143,260 | +58.6% | 0.00% | – |
| Q2 2022 | $1,366,000 | -44.5% | 90,300 | -56.4% | 0.00% | – |
| Q1 2022 | $2,460,000 | +20.7% | 207,027 | +64.7% | 0.00% | – |
| Q4 2021 | $2,038,000 | -38.2% | 125,698 | +8.7% | 0.00% | -100.0% |
| Q3 2021 | $3,300,000 | -44.3% | 115,615 | -34.0% | 0.00% | 0.0% |
| Q2 2021 | $5,921,000 | +114.2% | 175,185 | +91.7% | 0.00% | 0.0% |
| Q1 2021 | $2,764,000 | -51.7% | 91,395 | -20.8% | 0.00% | 0.0% |
| Q4 2020 | $5,717,000 | +1524.1% | 115,469 | +1159.5% | 0.00% | – |
| Q3 2020 | $352,000 | -37.3% | 9,168 | -29.5% | 0.00% | – |
| Q2 2020 | $561,000 | -43.3% | 13,000 | -65.7% | 0.00% | – |
| Q1 2020 | $990,000 | -54.9% | 37,913 | -46.1% | 0.00% | -100.0% |
| Q4 2019 | $2,197,000 | – | 70,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $108,639,000 | 6.47% |
| Memorial Sloan Kettering Cancer Center | 216,916 | $10,740,000 | 4.55% |
| Burrage Capital Management LLC | 114,962 | $5,692,000 | 4.34% |
| MPM BioImpact LLC | 674,582 | $33,398,000 | 2.88% |
| First Light Asset Management, LLC | 635,652 | $31,471,000 | 2.33% |
| Cormorant Asset Management, LP | 1,661,647 | $82,268,000 | 1.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 219,419 | $10,863,000 | 1.05% |
| ORACLE INVESTMENT MANAGEMENT INC | 126,342 | $6,255,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 131,016 | $6,487,000 | 0.58% |
| Artal Group S.A. | 285,028 | $14,112,000 | 0.30% |